USE OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH LYMPHOID MALIGNANCIES TRANSPLANTED WITH UNPURGED OR ADJUSTED-DOSE MAFOSFAMIDE-PURGED AUTOLOGOUS MARROW